Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism. [electronic resource]
Producer: 20030618Description: 1018-25 p. digitalISSN:- 0022-3042
- Amidohydrolases -- metabolism
- Animals
- Antiparkinson Agents -- therapeutic use
- Arachidonic Acids -- metabolism
- Binding, Competitive -- drug effects
- Cannabinoid Receptor Modulators
- Cerebellum -- drug effects
- Corpus Striatum -- drug effects
- Cyclohexanols -- pharmacokinetics
- Disease Models, Animal
- Endocannabinoids
- Excitatory Postsynaptic Potentials -- drug effects
- Fatty Acids, Unsaturated -- metabolism
- Glutamic Acid -- metabolism
- Glycerides -- metabolism
- In Vitro Techniques
- Levodopa -- therapeutic use
- Oxidopamine
- Parkinsonian Disorders -- chemically induced
- Patch-Clamp Techniques
- Phospholipase D -- metabolism
- Polyunsaturated Alkamides
- Rats
- Rats, Wistar
- Receptors, Cannabinoid
- Receptors, Drug -- agonists
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.